Direct detection of micro-strabismus and amblyopia (lazy eye) is now possible!
blinq (pediatric vision scanner) is the first instrument designed for vision screening programs that actually detects micro-strabismus and amblyopia. Using a novel new technology, blinq conducts a 2-second Neural Performance Scan of the fovea to accurately detect binocularity associated with as little as 1-degree misalignment.
What is a Neural Performance Scan?
Using proprietary retinal polarization scanning to measure bilateral fixation via fibers of the fovea, NPS precisely measures retinal nerve fiber patterns, instantly determining if fault fixation is present. NPS is cleared by the FDA for screening of micro-strabismus and amblyopia (lazy eye).
“Vision screening is strongly recommended by the American Academy of Pediatrics over the course of childhood to detect amblyopia to allow successful treatment”
-AMERICAN ASSOCIATION FOR PEDIATRIC OPHTHALMOLOGY AND STRABISMUS
Why is direct detection
Clinical studies funded by the NIH/NEI have shown that screening with Rebion's blinq technology is a dramatically more accurate approach to measuring for amblyopia than methods which merely collect data on amblyopia risk factors (ARF).* Greater accuracy leads to a reduction in care costs while improving patient outcomes.
*JAMA Ophthamol. 2014;132(7):814-820.doi:10.1001/jamaophthalmol.2014.424. Published online May 29, 2014.
Amblyopia represents a syndrome of compromised deficits:
Decreased Depth Perception (Stereopsis)
Reduced Visual Acuity (20/40 or Greater Corrected)
“The Pediatric Vision Scanner provides a novel method of screening directly for amblyopia, rather than for its risk factors.”
— JONATHAN M. HOLMES, BM, BCH COMMENTARY FOR JAMA JULY 2014
Why choose blinq?
blinq is a new technology that can empower vision screening staff to detect amblyopia and strabismus in preschool children with high sensitivity and specificity to drastically improve the effectiveness of vision screening worldwide.
97% sensitivity yields a high level of pass assurance, while 87% specificity reduces the cost and burden of over-referrals. blinq may be reimbursable, contact your representative for more information.
Definitive “pass” and “refer” output for amblyopia, including refractive amblyopia, micro strabismus, and strabismus
Eliminates interpretation of confounding data
blinq is designed to meet today’s screening needs
Encrypted data enables screening programs to remain HIPAA compliant and secure patient privacy
Intuitive data management applications on the device and tandem web-based tools
Wirelessly “push” patient list to blinq and “pull” screening results, eliminating the paper-trail and floating USB sticks